Study on the application of alfentanil combined with desflurane in the arousal of peripheral functional tumors

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044012

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-03-05

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral functional tumor

Interventions

Group D: desflurane remifentanil :Desflurane

Group S: sevoflurane remifentani:sevoflurane

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patient is older than 18 years of age; 2. ASA (American Association of Anesthesiologists Score) I or II; 3. no sensorimotor deficits before surgery, with the completion of intraoperative arousal.

Exclusion criteria

Exclusion criteria: 1. The patient is allergic to halogens inhalation anesthetics. 2. Malignant hyperpyrexia patients; 3. Increased intracranial pressure; 4. Have Mood Disorder; 5. ADHD; history of Surgery; 6. Have Mental Retardation; visual and hearing impairment;. 7. History of congenital heart disease; major organ dysfunction; 8. History of Drug Abuse, history of epilepsy, pre-op respiratory tract infection.

Design outcomes

Primary

Measure	Time frame
Blood pressure;Heart rate;Suction function;Cognitive function;	—

Countries

China

Contacts

Public ContactXiaoshi Liu

Fushun Mining Bureau General Hospital of Liaoning Health Industry Group

15668563248@163.com+86 15668563248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026